Infection of neurons by varicella-zoster virus (VZV) is not well understood, although it is a serious medical problem. VZV infects and becomes latent in dorsal root ganglia (DRG) during varicella. Subsequent reactivation of VZV gives rise to zoster (shingles). It has previously been difficult to study VZV latency and reactivation because of the virus' limited host range and the consequent lack of suitable animal or in vitro neuronal models. Identification of viral genes expressed during latency has been complicated by the potential problem of distinguishing latent from reactivating virus in ganglia obtained at autopsy. They propose to take advantage of an in situ hybridization -based method that permits human DRG neurons harboring latent or reactivating VZV to be distinguished. To identify viral genes which may be involved in latency, they will analyze viral gene expression in individual human DRG cells which are determined in serial section to contain latent or reactivating VZV. A multiplex method of in situ hybridization will be employed to identify every VZV open reading frame (ORF) expressed during latent infection. The abundance of these transcripts will be quantified by RT-PCR. Purified antibodies to representative proteins of the three major kinetic classes of VZV genes have been prepared and will also be used to identify protein expression during latent infection in human ganglia. They will attempt also to confirm the recent demonstration that VZV can infect rat DRG. To validate the use of rat DRG as a model of VZV latency, they will compare VZV gene expression during latency in rat DRG neurons with those expressed in their human counterparts in latent infection. The relative contributions made by viremia and retrograde transport in enabling VZV to infect rat DRG cells will be studied. Finally, the relative abilities of wild-type VZV and vaccine type (Oka) VZV to infect rat DRG will be determined. VZV latency will also be examined in cultured hNT neurons (postmitotic human neurons that differentiate in vitro from proliferating neuronal precursors). They will investigate gene expression during putative latency, including the comparative virulence of wild type and vaccine type VZV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI024021-14
Application #
6373098
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Beisel, Christopher E
Project Start
1990-02-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
14
Fiscal Year
2001
Total Cost
$308,170
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pediatrics
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Fukuyo, Yayoi; Horikoshi, Nobuo; Ishov, Alexander M et al. (2011) The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1. J Virol 85:3356-66
Walters, Matthew S; Kyratsous, Christos A; Silverstein, Saul J (2010) The RING finger domain of Varicella-Zoster virus ORF61p has E3 ubiquitin ligase activity that is essential for efficient autoubiquitination and dispersion of Sp100-containing nuclear bodies. J Virol 84:6861-5
Son, Moeun; Shapiro, Eugene D; LaRussa, Philip et al. (2010) Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis 201:1806-10
Mueller, Niklaus H; Walters, Matthew S; Marcus, Roland A et al. (2010) Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63. J Gen Virol 91:1133-7
Gershon, Anne A; Gershon, Michael D (2010) Perspectives on vaccines against varicella-zoster virus infections. Curr Top Microbiol Immunol 342:359-72
Walters, Matthew S; Kinchington, Paul R; Banfield, Bruce W et al. (2010) Hyperphosphorylation of histone deacetylase 2 by alphaherpesvirus US3 kinases. J Virol 84:9666-76
Gershon, Michael D; Gershon, Anne A (2010) VZV infection of keratinocytes: production of cell-free infectious virions in vivo. Curr Top Microbiol Immunol 342:173-88
Kyratsous, Christos A; Silverstein, Saul J; DeLong, Christine R et al. (2009) Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli. Gene 440:9-15
Kyratsous, Christos A; Silverstein, Saul J (2009) Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. J Virol 83:4262-74
Walters, Matthew S; Erazo, Angela; Kinchington, Paul R et al. (2009) Histone deacetylases 1 and 2 are phosphorylated at novel sites during varicella-zoster virus infection. J Virol 83:11502-13

Showing the most recent 10 out of 15 publications